- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Stable Growth Stocks
Danish Pharmaceuticals & Biotech Stable Growth Stocks
Results
3
0 new
3 companies
Genmab
Market Cap: DKK 85.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,379.50
7D
1.4%
1Y
-28.8%
H. Lundbeck
Market Cap: DKK 34.8b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 36.34
7D
-2.1%
1Y
-3.7%
ALK-Abelló
Market Cap: DKK 39.3b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 177.90
7D
2.5%
1Y
16.6%